{"id":"W2604623769","doi":"10.1016/j.jcjd.2017.08.242","title":"Glucagon-like Peptide-1 Receptor Agonists: A Class Update for Treating Type 2 Diabetes","year":2017,"lang":"en","type":"review","venue":"Canadian Journal of Diabetes","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Type 2 diabetes; Semaglutide; Liraglutide; Lixisenatide; Incretin; Exenatide; Hypoglycemia; Drug class; Diabetes mellitus; Intensive care medicine; Endocrinology; Pharmacology; Drug","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008997944,0.001000343,0.002310101,0.002457759,0.0002684188,0.001261347,0.001205127,0.001369201,0.00546942],"category_scores_gemma":[0.001132057,0.0003431618,0.001050827,0.002285563,0.0003751443,0.001437009,0.0008300506,0.002988076,0.001822021],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006234355,"about_ca_system_score_gemma":0.001367732,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001848063,"about_ca_topic_score_gemma":0.005622347,"domain_scores_codex":[0.9997171,0.0000412031,0.0000591827,0.00003927071,0.0001118037,0.00003142342],"domain_scores_gemma":[0.9993629,0.0002800185,0.0001358616,0.000009670495,0.0001497389,0.0000619284],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002291482,0.00009277817,0.0001670297,0.02742986,0.0002535182,0.0002014158,0.0000383734,0.0002269889,0.0008849583,0.001293374,0.06646907,0.9027135],"study_design_scores_gemma":[0.0002928298,0.0002598845,0.001238998,0.01017605,0.0009677517,0.001566808,0.00006250709,0.0002250321,0.0002339055,0.00116121,0.9837725,0.00004264589],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006203814,0.9988526,0.00007190924,0.0002896873,0.0002873784,0.000004491071,0.00002715979,0.00000812067,0.0003965241],"genre_scores_gemma":[0.0003671332,0.9983534,0.0001831062,0.000530722,0.0002700782,0.000005149539,0.00003854324,0.000001490035,0.0002504243],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00546942,"threshold_uncertainty_score":0.01829702,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05117790030075134,"score_gpt":0.3166139700665522,"score_spread":0.2654360697658008,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}